2025年中医药传承创新发展创新创业联合基金项目申报指南

Authors

  • 开元教育科技(深圳)有限公司 Author

DOI:

https://doi.org/10.6938/iie.070111

Keywords:

产学合作, 协同育人, 联合基金, 中医药, 创新发展

Abstract

2025年,开元教育科技(深圳)有限公司设立教育部产学合作协同育人项目中医药传承创新发展创新创业联合基金项目25项,旨在贯彻党的二十大报告“促进中医药传承创新发展”精神,贯彻落实《中共中央国务院关于促进中医药传承创新发展的意见》、国务院《中医药发展战略规划纲要(2016—2030年)》《“十四五”中医药发展规划》等文件精神,落实国家中医药发展战略,构建完善的中医药人才培养体系,推动中医药的传承与创新发展,提升中医药国际健康合作水平,弘扬中医药文化,以产业和技术发展的最新需求推动高校人才培养改革,促进中医药可持续发展。欢迎全国本科高校本科生、硕士生和博士生申报。

In 2025, Kaiyuan Education Technology (Shenzhen) Co., Ltd. will establish 25 projects under the Ministry of Education's Industry-Academia Collaboration Cooperative Education Program, focusing on the Innovation and Entrepreneurship Joint Fund for the Preservation and Innovative Development of Traditional Chinese Medicine (TCM). The initiative aims to implement the spirit of the 20th National Congress of the Communist Party of China, which emphasizes “promoting the preservation and innovative development of TCM.” It also seeks to fulfill the requirements of key national policy documents, including the Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Preservation and Innovative Development of TCM, the Outline of the Strategic Plan for TCM Development (2016–2030), and the 14th Five-Year Plan for TCM Development.  The program is aligned with the national TCM development strategy, focusing on building a comprehensive TCM talent cultivation system, advancing the preservation and innovative development of TCM, enhancing international health cooperation in TCM, and promoting TCM culture. By addressing the latest demands in industry and technology, it also aims to reform university talent cultivation and foster the sustainable development of TCM.  Undergraduate, master’s, and doctoral students from universities across the country are encouraged to apply.

Downloads

Published

2025-01-31

Share

Most read articles by the same author(s)

<< < 1 2 3 > >> 

Similar Articles

1-10 of 49

You may also start an advanced similarity search for this article.